London-based investment firm H2 Equity Partners is acquiring pan-European ophthalmology group Optegra International in a deal expected to complete early next year.

Optegra operates 23 eye hospitals across the UK, the Czech Republic and Poland, providing a range of critical eye-care services including cataract surgeries, age-related macular degeneration, and vision correction procedures. The business provides eye-care to publicly funded national healthcare systems such as the NHS, as well as to self-pay patients.

The group has a top-three market positions in each of the countries in which it operates and has says it has well invested facilities with ample capacity to support future growth.

Optegra stated that following the investment, its management team led by chief executive Dr Peter Byloos (pictured) will work closely with H2 to deliver an ambitious growth strategy.

H2 Equity Partners Fund V was launched in February 2017 and makes investments in the UK, Ireland and the Benelux. Optegra is Fund V’s ninth investment.

Date published: November 26, 2020

Subscriber content

To get unlimited access subscribe today

Subscribe

Already a subscriber? Login